Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianxiang Yu

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Diagnostics (Basel, Switzerland)|December 11, 2025
Multimodal Deep Learning-Based Classification of Breast Non-Mass Lesions Using Gray Scale and Color Doppler UltrasoundTianjiao Wang, Qingli Zhu, Tianxiang Yu, et al.
The Oncologist|July 14, 2025
Combination therapy for platinum-resistant ovarian cancer: a novel at-home regimen with envafolimab, lenvatinib, and etoposideBo Ding, Tianxiang Yu, Shiya Zheng, et al.
Communications Biology|August 2, 2024
High-complexity of DNA double-strand breaks is key for alternative end-joining choiceZhiyang Hou, Tianxiang Yu, Qiyi Yi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 7, 2022
Diacerein protects liver against APAP-induced injury via targeting JNK and inhibiting JNK-mediated oxidative stress and apoptosisMengyang Wang, Jinfeng Sun, Tianxiang Yu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2022
Corynoline protects ang II-induced hypertensive heart failure by increasing PPARα and Inhibiting NF-κB pathwayMengyang Wang, Wu Luo, Tianxiang Yu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 5, 2026
Corrigendum to "Diacerein protects liver against APAP-induced injury via targeting JNK and inhibiting JNK-mediated oxidative stress and apoptosis" [Biomed. Pharmacother. 149(2022) 112917]Mengyang Wang, Jinfeng Sun, Tianxiang Yu, et al.
Cellular and Molecular Life Sciences : CMLS|January 10, 2024
JOSD2 mediates isoprenaline-induced heart failure by deubiquitinating CaMKIIδ in cardiomyocytesJiachen Xu, Shiqi Liang, Qinyan Wang, et al.
Theranostics|May 8, 2023
OTUD1 promotes pathological cardiac remodeling and heart failure by targeting STAT3 in cardiomyocytesMengyang Wang, Xue Han, Tianxiang Yu, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 28, 2024
Compound SJ-12 attenuates streptozocin-induced diabetic cardiomyopathy by stabilizing SERCA2aShuaijie Lou, Weiwei Zhu, Tianxiang Yu, et al.
European Heart Journal|May 21, 2025
Checkpoint kinase Wee1 activation drives inflammation and hypertrophy through the protein kinase B/phosphoinositide 3-kinases-nuclear factor κB pathway in cardiomyocytesMengyang Wang, Xue Han, Qinyan Wang, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Diagnostics (Basel, Switzerland)|December 11, 2025
Multimodal Deep Learning-Based Classification of Breast Non-Mass Lesions Using Gray Scale and Color Doppler UltrasoundTianjiao Wang, Qingli Zhu, Tianxiang Yu, et al.
The Oncologist|July 14, 2025
Combination therapy for platinum-resistant ovarian cancer: a novel at-home regimen with envafolimab, lenvatinib, and etoposideBo Ding, Tianxiang Yu, Shiya Zheng, et al.
Communications Biology|August 2, 2024
High-complexity of DNA double-strand breaks is key for alternative end-joining choiceZhiyang Hou, Tianxiang Yu, Qiyi Yi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 7, 2022
Diacerein protects liver against APAP-induced injury via targeting JNK and inhibiting JNK-mediated oxidative stress and apoptosisMengyang Wang, Jinfeng Sun, Tianxiang Yu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 5, 2022
Corynoline protects ang II-induced hypertensive heart failure by increasing PPARα and Inhibiting NF-κB pathwayMengyang Wang, Wu Luo, Tianxiang Yu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 5, 2026
Corrigendum to "Diacerein protects liver against APAP-induced injury via targeting JNK and inhibiting JNK-mediated oxidative stress and apoptosis" [Biomed. Pharmacother. 149(2022) 112917]Mengyang Wang, Jinfeng Sun, Tianxiang Yu, et al.
Cellular and Molecular Life Sciences : CMLS|January 10, 2024
JOSD2 mediates isoprenaline-induced heart failure by deubiquitinating CaMKIIδ in cardiomyocytesJiachen Xu, Shiqi Liang, Qinyan Wang, et al.
Theranostics|May 8, 2023
OTUD1 promotes pathological cardiac remodeling and heart failure by targeting STAT3 in cardiomyocytesMengyang Wang, Xue Han, Tianxiang Yu, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 28, 2024
Compound SJ-12 attenuates streptozocin-induced diabetic cardiomyopathy by stabilizing SERCA2aShuaijie Lou, Weiwei Zhu, Tianxiang Yu, et al.
European Heart Journal|May 21, 2025
Checkpoint kinase Wee1 activation drives inflammation and hypertrophy through the protein kinase B/phosphoinositide 3-kinases-nuclear factor κB pathway in cardiomyocytesMengyang Wang, Xue Han, Qinyan Wang, et al.
Pageof 3